Replies to post #56681 on PharmaCyte Biotech Inc (PMCB)

[dealerschool2006]

I'm talking about this from 10-Q..."During the six months ended October 31, 2016, the Company acquired funds through the Company’s S-3 Registration Statement pursuant to which its exclusive placement agent, Chardan Capital Markets, LLC (“Chardan”), sold shares of common stock “at-the-market” or in negotiated block trades in a program which is structured to provide up to $50 million dollars to the Company less certain commissions.

That would put 1billion shares of PMCB in open market @ .05 more if the pps was lower...that's a lot of shares...